Kobayashi H - Search Results

1

Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.

Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, Shimizu T, Kawakami A, Tanaka K, Tsuji T, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, Nakajima H; Japan VEXAS study group. Kirino Y, et al. Among authors: kobayashi h, kobayashi d. Rheumatology (Oxford). 2024 Sep 28:keae530. doi: 10.1093/rheumatology/keae530. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39340799

2

A Japanese case of VEXAS syndrome after COVID-19 vaccination: Comparison with previously reported cases.

Miyagi Y, Kobayashi H, Umebayashi Y, Okimura A, Nakatsugawa M, Maeda A, Kirino Y, Aoki A. Miyagi Y, et al. Among authors: kobayashi h. Mod Rheumatol Case Rep. 2024 Sep 7:rxae054. doi: 10.1093/mrcr/rxae054. Online ahead of print. Mod Rheumatol Case Rep. 2024. PMID: 39242354

3

Effects of apomorphine, physostigmine and vasoactive intestinal peptide on penile erection and yawning in diabetic rats.

Yamaguchi Y, Kobayashi H. Yamaguchi Y, et al. Among authors: kobayashi h. Eur J Pharmacol. 1994 Mar 11;254(1-2):91-6. doi: 10.1016/0014-2999(94)90374-3. Eur J Pharmacol. 1994. PMID: 8206121

4

Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat.

Yamaguchi Y, Kobayashi H. Yamaguchi Y, et al. Among authors: kobayashi h. Neuropeptides. 1994 Mar;26(3):153-8. doi: 10.1016/0143-4179(94)90124-4. Neuropeptides. 1994. PMID: 8208360

5

Effects of ginsenosides on impaired performance caused by scopolamine in rats.

Yamaguchi Y, Higashi M, Kobayashi H. Yamaguchi Y, et al. Among authors: kobayashi h. Eur J Pharmacol. 1996 Sep 26;312(2):149-51. doi: 10.1016/0014-2999(96)00597-3. Eur J Pharmacol. 1996. PMID: 8894589

6

Effects of ginsenosides on maze performance and brain choline acetyltransferase activity in scopolamine-treated young rats and aged rats.

Yamaguchi Y, Higashi M, Kobayashi H. Yamaguchi Y, et al. Among authors: kobayashi h. Eur J Pharmacol. 1997 Jun 18;329(1):37-41. doi: 10.1016/s0014-2999(97)10115-7. Eur J Pharmacol. 1997. PMID: 9218681

7

Effects of ginsenosides on impaired performance induced in the rat by scopolamine in a radial-arm maze.

Yamaguchi Y, Haruta K, Kobayashi H. Yamaguchi Y, et al. Among authors: kobayashi h. Psychoneuroendocrinology. 1995;20(6):645-53. doi: 10.1016/0306-4530(95)00008-c. Psychoneuroendocrinology. 1995. PMID: 8584605

8

COVID-19 survivors with calcineurin-inhibitors-treated rheumatoid arthritis.

Kobayashi H, Hirai Y, Aoki A. Kobayashi H, et al. Mod Rheumatol Case Rep. 2022 Jan 7;6(1):10-13. doi: 10.1093/mrcr/rxab023. Mod Rheumatol Case Rep. 2022. PMID: 34626196

9

Magnetization and neutron-diffraction studies of magnetic properties of single-crystal DyMn2Ge2.

Kobayashi H, Onodera H, Yamaguchi Y, Yamamoto H. Kobayashi H, et al. Phys Rev B Condens Matter. 1991 Jan 1;43(1):728-734. doi: 10.1103/physrevb.43.728. Phys Rev B Condens Matter. 1991. PMID: 9996266 No abstract available.

10

COVID-19 in an Adult with Down Syndrome: Impact on Autoimmune Response.

Kobayashi H, Akiniwa M, Yamaguchi Y, Hirai Y, Aoki A. Kobayashi H, et al. Case Rep Infect Dis. 2022 Apr 13;2022:6128496. doi: 10.1155/2022/6128496. eCollection 2022. Case Rep Infect Dis. 2022. PMID: 35433064 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,474 results

Search Page

Filters